The Enterprise Value as of June 2026 (TTM) for Trevi Therapeutics, Inc. (TRVI) is 2.00B

According to Trevi Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.00B. This represents a change of 48.33% compared to the average of 1.35B of the last 4 quarters.

Trevi Therapeutics, Inc. (TRVI) Historical Enterprise Value (quarterly & annually)

How has TRVI Enterprise Value performed in the past?

The mean historical Enterprise Value of Trevi Therapeutics, Inc. over the last ten years is 267.29M. The current 2.00B Enterprise Value has changed 74.68% with respect to the historical average. Over the past ten years (40 quarters), TRVI's Enterprise Value was at its highest in in the December 2025 quarter at 1.80B. The Enterprise Value was at its lowest in in the December 2021 quarter at -5299238.83.

Trevi Therapeutics, Inc. (TRVI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Trevi Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Trevi Therapeutics, Inc. (TRVI) Average Enterprise Value

How has TRVI Enterprise Value performed in the past?

The current Enterprise Value of Trevi Therapeutics, Inc. (TRVI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Trevi Therapeutics, Inc. (TRVI) Enterprise Value vs. Peers

How is TRVI’s Enterprise Value compared to its peers?

Trevi Therapeutics, Inc.’s Enterprise Value is greater than Ardelyx, Inc. (1.58B), greater than Wave Life Sciences Ltd. (600.52M), greater than Novavax, Inc. (1.53B), greater than Zenas BioPharma, Inc. (735.43M), greater than Upstream Bio, Inc. (236.35M), greater than Tourmaline Bio, Inc. (1.20B), less than Terns Pharmaceuticals, Inc. (4.25B), greater than Zymeworks Inc. (1.46B), greater than Precigen, Inc. (1.43B), greater than ORIC Pharmaceuticals, Inc. (799.69M),

Build a custom stock screener for Trevi Therapeutics, Inc. (TRVI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trevi Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Trevi Therapeutics, Inc. (TRVI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Trevi Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.